FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to field of biotechnology, in particular to obtaining stimulated dendritic cells (DC), and can be applied in medicine for immunotherapy of cancer. Mature pro-inflammatory DC is obtained by ex vivo induction of its maturation by processing immature DC with such substances as sodium salt of polyynosinic-polycytidinic acid (poly-Y:C), resiquimod (R848) and interferon-gamma (IFN-g), but not prostaglandin E2 (PGE2). Obtained DC is applied in treatment of cancer in individual by injection into tumour. Said pro-inflammatory mature DC is allogenic with respect to said individual.
EFFECT: invention makes it possible to efficiently inhibit proliferation of tumour cells.
14 cl, 14 dwg, 6 tbl
Title | Year | Author | Number |
---|---|---|---|
CO-DIFFERENTIATION OF MONOCYTES FROM ALLOGENEIC DONORS | 2013 |
|
RU2668816C2 |
METHOD OF GENERATING ANTIGEN-SPECIFIC OF CYTOTOXIC CELLS WITH ANTICANCER ACTIVITY | 2011 |
|
RU2458985C1 |
METHOD OF GENERATING CYTOTOXIC CELLS WITH ACTIVITY AGAINST NON-SMALL CELL LUNG CANCER CELLS | 2014 |
|
RU2577992C2 |
METHOD OF INDUCING CYTOTOXIC ANTI-TUMOUR IMMUNE RESPONSE in vitro WITH USING DENDRITIC CELLS, TRANSFECTED BY RNA TUMOUR CELLS, TO NON-SMALL CELL LUNG CANCER | 2015 |
|
RU2578008C1 |
AUTOLOGOUS VACCINE FOR ONCOTHERAPY AND METHOD FOR PREPARING THEREOF | 2008 |
|
RU2392946C2 |
GENERATION METHOD OF ANTIGEN-SPECIFIC CYTOTOXIC CELLS WITH ACTIVITY AGAINST OVARIAN CARCINOMA CELLS | 2012 |
|
RU2508298C2 |
COMBINED CELL TRANSPLANT BASED ON LYMPHOKINE-ACTIVATED KILLERS AND DENDRITE CELLS, METHOD FOR PRODUCTION THEREOF AND METHOD FOR TREATMENT AND PROPHYLAXIS OF MALIGNANT, INFECTIVE DISEASES AND IMMUNODEFICIENT CONDITIONS | 2006 |
|
RU2309753C1 |
METHOD OF ANTITUMOUR IMMUNOTHERAPY | 2012 |
|
RU2530523C2 |
METHOD FOR OBTAINING ANTIGEN SPECIFIC CYTOTOXIC CELLS WITH ANTI-TUMOR CYTOTOXIC ACTIVITY AGAINST CELLS OF NON-SMALL CELLS LUNG CANCER | 2016 |
|
RU2639514C1 |
METHOD OF GENERATING ANTIGEN-SPECIFIC CYTOTOXIC CELLS WITH ANTITUMOUR ACTIVITY IN BREAST CANCER | 2013 |
|
RU2521506C1 |
Authors
Dates
2015-10-20—Published
2011-02-10—Filed